RecruitingNCT07650773
Oncology
Adult hepatocellular carcinoma
40
studies recruiting now
as of 7 Sept 2026
352
studies registered in total
as of 7 Sept 2026
17
countries with a recruiting site
as of 7 Sept 2026
16 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07391670
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
RecruitingPhase 1 / Phase 2NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1NCT06084481
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RecruitingPhase 1 / Phase 2NCT07227012
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 40 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Adult hepatocellular carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Adult hepatocellular carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (AXIN1, PIK3CA, CASP8, TP53, PDGFRL, CTNNB1).
Treatments being studied
13 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Bevacizumab (Abevmy)
Phase 2Ixabepilone (Ixempra kit)
Phase 2Lapatinib Ditosylate (Tykerb)
Phase 2Oxaliplatin (Eloxatin)
Phase 2Gefitinib (Gefitinib mylan)
Phase 2Cixutumumab
Phase 2Uracil
Phase 2Selumetinib
+ 5 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).